Dextrose Monohydrate 5% Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dextrose Monohydrate 5% Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 02/14/2022. Reported reason: Demand increase for the drug
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 65219-462-10
- Dosage Form
- Injection
- Presentation
- Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-462-10)
- Initial Posting
- 02/14/2022
- Revised Date
Reason
Demand increase for the drug